drugset / Trial / NCT00687232

Safety, Tolerability and Pharmacokinetics of Inhaled Doses of AZD4818 in Healthy Japanese Male Volunteers

NCT00687232 ↗

Phase 1 Completed 30 enrolled AstraZeneca
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose is to investigate safety and tolerability of single and multiple ascending inhaled doses of AZD4818 in healthy Japanese male volunteers.

Timeline

Start
2008-01
Primary completion
2008-05
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD4818 Small molecule — Other

Indications

No indication recorded.